Scientific article
Review
OA Policy
English

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

Published inAnnals of the Rheumatic Diseases, vol. 80, no. 1, p. 71-87
Publication date2021
Abstract

Janus kinase inhibitors (JAKi) have been approved for use in various immune-mediated inflammatory diseases. With five agents licensed, it was timely to summarise the current understanding of JAKi use based on a systematic literature review (SLR) on efficacy and safety.

Keywords
  • Adamantane/analogs & derivatives/therapeutic use
  • Advisory Committees
  • Antirheumatic Agents/therapeutic use
  • Arthritis
  • Psoriatic/drug therapy/immunology
  • Arthritis
  • Rheumatoid/drug therapy/immunology
  • Azetidines/therapeutic use
  • Cytokines/immunology
  • Drug Therapy
  • Combination
  • Europe
  • Heterocyclic Compounds
  • 3-Ring/therapeutic use
  • Humans
  • Inflammatory Bowel Diseases/drug therapy/immunology
  • Janus Kinase Inhibitors/therapeutic use
  • Niacinamide/analogs & derivatives/therapeutic use
  • Piperidines/therapeutic use
  • Psoriasis/drug therapy/immunology
  • Purines/therapeutic use
  • Pyrazoles/therapeutic use
  • Pyridines/therapeutic use
  • Pyrimidines/therapeutic use
  • Rheumatology
  • Spondylarthropathies/drug therapy/immunology
  • Spondylitis
  • Ankylosing/drug therapy/immunology
  • Sulfonamides/therapeutic use
  • Triazoles/therapeutic use
Citation (ISO format)
NASH, Peter et al. Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement. In: Annals of the Rheumatic Diseases, 2021, vol. 80, n° 1, p. 71–87. doi: 10.1136/annrheumdis-2020-218398
Main files (1)
Article (Published version)
Identifiers
Journal ISSN0003-4967
236views
110downloads

Technical informations

Creation30/04/2021 17:21:00
First validation30/04/2021 17:21:00
Update time16/03/2023 02:19:11
Status update16/03/2023 02:19:08
Last indexation01/11/2024 00:07:20
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack